Increased concentrations of plasma lactic dehydrogenase (LDH) were reported in chickens with clinical leukosis(1). These authors suggested that flocks could be screened, using this test, as had previously been done in bovine leukaemia(2). This paper reports the increase of plasma LDH activity in chickens experimentally infected with the Bryan high-titre strain of Rous sarcoma virus (BS-RSV). The results indicate its general unsuitability as a screening test in comparison with neutralizing antibodies.
older birds and smaller inocula in Expt 2 the intervals between antibody formation, LDH increase and death would be prolonged; this expectation was fulfilled.
Abnormally high levels of LDH in the plasma have been described in patients with active neoplastic disease (5) and tumour-bearing mice (6) . However, it was later shown that this abnormal enzyme activity was associated with a filterable agent which did not give rise to tumours (7) . It seems from the results reported here that avian leukosis viruses do not themselves cause an increase in LDH, nor do they carry an associated virus which does so. It is possible that the activity is a product of neoplastic cells. Avian leukosis viruses may be divided into two groups: those predominantly causing leukosis and those predominantly causing sarcomas. The former group may give a rapid rise in plasma LDH but the latter, of which BS-RSV is a member, evidently do not. We require for screening a test which detects all the leukoses; plainly, LDH levels do not provide a good basis for such a test since LDH activity is increased late in BS-RSV infection when the bird is virtually moribund and it would be much simpler to screen flocks for neutralizing antibody against a virus from each of the two major subgroups though this would have to be supplemented by COFAL(8) (complement fixation-avian leukosis) tests in groups of embryos to detect recent infections where antibody titres were still low.
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